Cargando…

Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease

Detalles Bibliográficos
Autores principales:	He, Ying, Guo, Xiao, Wang, Zaijie Jim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890007/ https://www.ncbi.nlm.nih.gov/pubmed/36300778 http://dx.doi.org/10.3324/haematol.2022.281716

Ejemplares similares

Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
por: Yimer, Ebrahim M., et al.
Publicado: (2019)

Beta2-Adrenergic Receptor Polymorphisms and Haplotypes Associate With Chronic Pain in Sickle Cell Disease
por: Jhun, Ellie H., et al.
Publicado: (2019)

Candidate gene association study suggests potential role of dopamine beta-hydroxylase in pain heterogeneity in sickle cell disease
por: Sadhu, Nilanjana, et al.
Publicado: (2023)

Biliary pseudolithiasis secondary to ceftriaxone therapy
por: Zaki, Syed Ahmed, et al.
Publicado: (2010)

1559. Ertapenem Plus Ceftriaxone or Ceftaroline Dual Β-Lactam Combination for Enterococcus faecalis
por: Cusumano, Jaclyn A, et al.
Publicado: (2019)

Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection
por: Novy, Emmanuel, et al.
Publicado: (2020)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017
por: Katz, Alan R.
Publicado: (2018)

Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina
por: Gianecini, Ricardo, et al.
Publicado: (2016)

Can ceftriaxone be omitted in the treatment of nongonococcal pelvic inflammatory disease?
por: Ross, James Ian McConville, et al.
Publicado: (2021)

Vasopressin SNP pain factors and stress in sickle cell disease
por: Powell-Roach, Keesha L., et al.
Publicado: (2019)

S100B single nucleotide polymorphisms exhibit sex-specific associations with chronic pain in sickle cell disease in a largely African-American cohort
por: Jhun, Ellie H., et al.
Publicado: (2020)

Screening of medicinal plants for antibacterial principles against β-lactam resistant strains
por: Vinod, N.V., et al.
Publicado: (2011)

β–Lactams and Tetracyclines Antibiotic Residue Detection in Bulk Tank Milk in Iran
por: MOKHTARI, Alireza, et al.
Publicado: (2013)

In Vitro Susceptibility of Clinical Isolates to Ceftriaxone Alone and Ceftriaxone in Combination With Sulbactam or Tazobactam: A Comparative Study of Broad-Spectrum β-Lactam Antibiotics in India
por: Sanghavi, Sonali, et al.
Publicado: (2023)

Management of Patients with Sickle Cell Pain in the Community
por: Edmonds, Polly, et al.
Publicado: (1999)

Treatment of Chronic Back and Chest Pain in a Patient with Sickle Cell Disease Using Spinal Cord Stimulation
por: Yürük, Damla, et al.
Publicado: (2018)

Ceftriaxone induced immune hemolytic anemia with disseminated intravascular coagulation
por: Shrimali, Jigar D., et al.
Publicado: (2013)

Accuracy in diagnosis of allergy to β-lactams
por: Iglesias-Souto, Javier, et al.
Publicado: (2012)

New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan
por: Deguchi, Takashi, et al.
Publicado: (2016)

Ceftriaxone-Induced Neutropenia Successfully Treated With Alternative β-Lactam Antibiotics: A Case Report and Review of the Literature
por: Satake, Kana, et al.
Publicado: (2023)

Not all β-lactams are equal regarding neurotoxicity
por: Chaïbi, Khalil, et al.
Publicado: (2016)

Repetitive transcranial magnetic stimulation: a potential therapeutic modality for chronic low back pain
por: Shafiee, Sajad, et al.
Publicado: (2017)

Ceftriaxone, a Beta-Lactam Antibiotic, Modulates Apoptosis Pathways and Oxidative Stress in a Rat Model of Neuropathic Pain
por: Amin, Bahareh, et al.
Publicado: (2014)

Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria
por: Gonzalez, Mark D., et al.
Publicado: (2017)

Marked Direct Hyperbilirubinemia due to Ceftriaxone in an Adult with Sickle Cell Disease
por: Khurram, Daniyeh, et al.
Publicado: (2015)

Is β-lactamase testing acceptably accurate for predicting Haemophilus influenzae susceptibility to β-lactams? Epidemiological data from Philadelphia, USA, 2017–2023
por: Morton, Arianna B., et al.
Publicado: (2023)

Performance of Antipseudomonal β-Lactams on the Accelerate PhenoTest BC Kit against a Collection of Pseudomonas aeruginosa Isolates
por: Sikorski, Aaron, et al.
Publicado: (2021)

Sickle cell-β thalassemia with concomitant hemophilia A: a rare presentation
por: Dhiman, Pratibha, et al.
Publicado: (2015)

Why Did the Patient Not Show Any Neurological Symptoms on the Day of the Higher Serum Concentration of Ceftriaxone?
por: Fukuchi, Takahiko, et al.
Publicado: (2019)

Myocardial injury and coronary microvascular disease in sickle cell disease
por: Kaur, Kiranveer, et al.
Publicado: (2021)

Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan
por: Ohnishi, Makoto, et al.
Publicado: (2011)

Ocular manifestations of sickle cell disease
por: Joob, Beuy, et al.
Publicado: (2018)

Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015–2017
por: Shaskolskiy, Boris, et al.
Publicado: (2019)

Cyclic Guanosine Monophosphate-Dependent Protein Kinase I Stimulators and Activators Are Therapeutic Alternatives for Sickle Cell Disease
por: Ghanta, Mohankrishna, et al.
Publicado: (2018)

Author's Reply: Why Did the Patient Not Show Any Neurological Symptoms on the Day of the Higher Serum Concentration of Ceftriaxone?
por: Suzuki, Soichiro, et al.
Publicado: (2019)

Renal replacement therapy does have impact on beta-lactam clearance
por: Yu, Zhenwei
Publicado: (2023)

Comment on: CG258 Klebsiella pneumoniae isolates without β-lactam resistance at the onset of the carbapenem-resistant Enterobacteriaceae epidemic in New York City
por: Wyres, Kelly L, et al.
Publicado: (2019)

Sickle Cell Disease and Bartonella Spp. Infection
por: Velho, Paulo Eduardo Neves Ferreira, et al.
Publicado: (2012)

Analysis of AVPR1A, thermal and pressure pain thresholds, and stress in sickle cell disease
por: Powell-Roach, Keesha L., et al.
Publicado: (2023)

Chronic Active Parietal Osteomyelitis Due to Salmonella typhi in a Patient with Sickle Cell Anemia
por: Antar, Ahmad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sp0rvp8t0ldf6bvmlejkfchap9